Primary Category:
Treatment Protocols
Disease Category:
Genitourinary, Prostate Metastatic
Status:
Open
CASPAR – A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
Eligible for screening study DCP 001
A031902 is reactivated to new patient enrollment, effective July 27, 2021.
NCT#04455750
